摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 3-(methoxycarbonylmethyl)-1H-indole-2-carboxylate | 156362-00-4

中文名称
——
中文别名
——
英文名称
methyl 3-(methoxycarbonylmethyl)-1H-indole-2-carboxylate
英文别名
methyl 3-(2-methoxy-2-oxoethyl)-1H-indole-2-carboxylate;methyl 2-(2-methoxycarbonyl-1H-indole-3-yl)acetate;methyl 3-methoxycarbonylmethylindole-2-carboxylate;Methyl 2-(2-methoxycarbonyl-1H-indol-3-yl)acetate;(2-methoxycarbonyl-indol-3-yl)-acetic acid methyl ester;(2-Methoxycarbonyl-indol-3-yl)-essigsaeure-methylester
methyl 3-(methoxycarbonylmethyl)-1H-indole-2-carboxylate化学式
CAS
156362-00-4
化学式
C13H13NO4
mdl
MFCD14281647
分子量
247.251
InChiKey
DTWHLOFDTYAJEL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    426.3±35.0 °C(Predicted)
  • 密度:
    1.283±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    68.4
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 储存条件:
    存储在室温下

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 3-(methoxycarbonylmethyl)-1H-indole-2-carboxylate 在 lithium hydroxide 作用下, 以 四氢呋喃 为溶剂, 以90%的产率得到3-(羧甲基)-1H-吲哚-2-羧酸
    参考文献:
    名称:
    Indole- and indoline-based kainate analogues with antagonist activity at ionotropic glutamate receptors
    摘要:
    A conformationally constrained, indole-based kainate analogue was designed based on Gouaux's X-ray structure of kainic acid bound to an iGluR2(S1S2) construct, a structural model for AMPA/kamate ionotropic glutamate receptors. In contrast to the parent kainic acid, a potent agonist, this compound, along with three structurally related analogues derived from synthetic intermediates, exhibited antagonist behavior towards KAR expressed in oocytes, a result that is rationalized by molecular modeling studies. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.05.098
  • 作为产物:
    描述:
    参考文献:
    名称:
    Indole- and indoline-based kainate analogues with antagonist activity at ionotropic glutamate receptors
    摘要:
    A conformationally constrained, indole-based kainate analogue was designed based on Gouaux's X-ray structure of kainic acid bound to an iGluR2(S1S2) construct, a structural model for AMPA/kamate ionotropic glutamate receptors. In contrast to the parent kainic acid, a potent agonist, this compound, along with three structurally related analogues derived from synthetic intermediates, exhibited antagonist behavior towards KAR expressed in oocytes, a result that is rationalized by molecular modeling studies. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.05.098
点击查看最新优质反应信息

文献信息

  • PdII-Catalyzed CH Olefination of N-(2-Pyridyl)sulfonyl Anilines and Arylalkylamines
    作者:Alfonso García-Rubia、Beatriz Urones、Ramón Gómez Arrayás、Juan C. Carretero
    DOI:10.1002/anie.201105611
    日期:2011.11.11
    N‐(2‐pyridyl)sulfonyl group acts as a removable directing group in the PdII‐catalyzed aryl CH ortho alkenylation of N‐alkyl aniline, benzylamine, and phenethylamine derivatives with electron‐poor alkenes. The products were obtained in high yields (70–90 %) and with complete regiocontrol. The mild reductive N‐sulfonyl removal enables the construction of a variety of nitrogen heterocycles. EWG=electron‐withdrawing
    柔性朋友:本ñ - (2-吡啶基)磺酰基作为在钯可拆卸的定向基团II催化的芳基C  ħ邻位 的烯基化Ñ烷基苯胺,苄胺,和苯乙胺与缺电子烯烃衍生物。获得的产品收率高(70–90%),并且具有完全的区域控制能力。温和的还原性N-磺酰基去除可构建各种氮杂环。EWG =吸电子基团。
  • Visible-Light-Induced Direct Photocatalytic Carboxylation of Indoles with CBr<sub>4</sub>/MeOH
    作者:Qing-Qing Yang、Marianna Marchini、Wen-Jing Xiao、Paola Ceroni、Marco Bandini
    DOI:10.1002/chem.201503787
    日期:2015.12.7
    Photocatalysis enables the cascade reactions of indoles and CBr4 in MeOH through a C(sp2)H functionalization/methanolysis sequence. The title reaction provides an efficient access to indole 2‐ and 3‐carboxylates in a single operation (no preinstallation of protecting as well as directing groups was required) with good yields under mild reaction conditions.
    光催化通过C(sp 2)H官能化/甲烷分解序列实现吲哚和CBr 4在MeOH中的级联反应。标题反应可在温和的反应条件下以高收率在一次操作中高效获得吲哚2和3-羧酸酯(无需预先安装保护基团和导向基团)。
  • Synthesis of 2,3-Disubstituted Indoles by Palladium-Mediated Coupling of 2-Iodoindoles
    作者:Hidetoshi Tokuyama、Yosuke Kaburagi、Xiaoqi Chen、Tohru Fukuyama
    DOI:10.1055/s-2000-6354
    日期:——
    N-Unprotected 2-iodoindoles are synthesized by treatment of 2-stannylindoles with iodine, which in turn are prepared by tin-mediated radical cyclization of 2-alkenylphenylisocyanides. Palladium-catalyzed coupling reactions of N-unprotected 2-iodoindoles with terminal acetylenes, terminal olefins, carbonylation, and the Suzuki coupling reaction with phenyl borate proceed smoothly to furnish the corresponding 2,3-disubstituted indoles in good to excellent yields.
    N-未保护的2-碘吲哚通过将2-锡烯吲哚与碘反应合成,这些2-锡烯吲哚又是通过锡催化的自由基环化反应与2-烯基苯异氰酸酯制备的。N-未保护的2-碘吲哚与末端炔烃、末端烯烃的镍催化耦合反应,以及与苯硼酸的铃木耦合反应均顺利进行,生成相应的2,3-二取代吲哚,产率良好至优异。
  • Chemical compounds
    申请人:AstraZeneca AB
    公开号:US06833387B1
    公开(公告)日:2004-12-21
    The use of a 3-substituted indole compound of formula (I) or a pharmaceutically acceptable salt, amide or ester thereof; X is CH2 or SO2 and R1, R2, R3, R4, R5, R6 and R7 are certain specified organic moieties, for use in the preparation of a medicament for the inhibition of monocyte chemoattractant protein-1 and/or RANTES induced chemotaxis. Pharmaceutical compositions containing certain compounds of formula (I) and novel compounds of formula (I) are also described and claimed.
    使用式(I)的3-取代吲哚化合物或其药学上可接受的盐、酰胺或酯;X为CH2或SO2,R1、R2、R3、R4、R5、R6和R7为特定指定的有机基团,用于制备用于抑制单核细胞趋化蛋白-1和/或RANTES诱导趋化的药物。还描述和声明了含有式(I)的某些化合物和式(I)的新化合物的药物组合物。
  • Fused pyrrole derivatives
    申请人:Banner David
    公开号:US20070142452A1
    公开(公告)日:2007-06-21
    The invention is concerned with novel fused pyrrole derivatives of formula (I) wherein A, Ar, R 1 , R 2 , R 2′ and R 2″ and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit chymase and can be used as medicaments.
    这项发明涉及式(I)的新型融合吡咯衍生物,其中A、Ar、R1、R2、R2′和R2″以及n的定义如描述和权利要求中所定义,并且其生理上可接受的盐。这些化合物抑制chymase并可用作药物。
查看更多

同类化合物

(Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (R)-(+)-5'-苄氧基卡维地洛 (R)-卡洛芬 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (3Z)-3-(1H-咪唑-5-基亚甲基)-5-甲氧基-1H-吲哚-2-酮 (3Z)-3-[[[4-(二甲基氨基)苯基]亚甲基]-1H-吲哚-2-酮 (3R)-(-)-3-(1-甲基吲哚-3-基)丁酸甲酯 (3-氯-4,5-二氢-1,2-恶唑-5-基)(1,3-二氧代-1,3-二氢-2H-异吲哚-2-基)乙酸 齐多美辛 鸭脚树叶碱 鸭脚木碱,鸡骨常山碱 鲜麦得新糖 高氯酸1,1’-二(十六烷基)-3,3,3’,3’-四甲基吲哚碳菁 马鲁司特 马来酸阿洛司琼 马来酸替加色罗 顺式-ent-他达拉非 顺式-1,3,4,4a,5,9b-六氢-2H-吡啶并[4,3-b]吲哚-2-甲酸乙酯 顺式-(+-)-3,4-二氢-8-氯-4'-甲基-4-(甲基氨基)-螺(苯并(cd)吲哚-5(1H),2'(5'H)-呋喃)-5'-酮 靛红联二甲酚 靛红磺酸钠 靛红磺酸 靛红乙烯硫代缩酮 靛红-7-甲酸甲酯 靛红-5-磺酸钠 靛红-5-磺酸 靛红-5-硫酸钠盐二水 靛红-5-甲酸甲酯 靛红 靛玉红3'-单肟5-磺酸 靛玉红-3'-单肟 靛玉红 青色素3联己酸染料,钾盐 雷马曲班 雷莫司琼杂质13 雷莫司琼杂质12 雷莫司琼杂质 雷替尼卜定 雄甾-1,4-二烯-3,17-二酮 阿霉素的代谢产物盐酸盐 阿贝卡尔 阿西美辛叔丁基酯 阿西美辛 阿莫曲普坦杂质1 阿莫曲普坦 阿莫曲坦二聚体杂质 阿莫曲坦 阿洛司琼杂质